These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 12194224

  • 21. Tick-borne encephalitis (TBE): an underestimated risk…still: report of the 14th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE).
    Kunze U, ISW-TBE.
    Ticks Tick Borne Dis; 2012 Jun; 3(3):197-201. PubMed ID: 22765977
    [Abstract] [Full Text] [Related]

  • 22. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C, Izu A, Petri E, Gniel D, Fragapane E.
    Vaccine; 2015 Apr 08; 33(15):1824-9. PubMed ID: 25728316
    [Abstract] [Full Text] [Related]

  • 23. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P, Kundi M, Zent O, Dvorak G, Jaehnig P, Holzmann H, Mikolasek A, Kollaritsch H.
    Vaccine; 2004 Jul 29; 22(21-22):2743-9. PubMed ID: 15246606
    [Abstract] [Full Text] [Related]

  • 24. [After vaccination for tick-borne encephalitis must onset of neurologic disorders be expected?].
    Hofmann H.
    Wien Klin Wochenschr; 1995 Jul 29; 107(17):509-15. PubMed ID: 7483633
    [Abstract] [Full Text] [Related]

  • 25. [Study of the reactivity and immunogenicity of FSME-IMMUN vaccine against tick-borne meningoencephalitis].
    Borcić B, Majerus-Misić L, Raos B, Punda V, Bujić N, Toth D.
    Lijec Vjesn; 1984 Oct 29; 106(10):425-8. PubMed ID: 6503595
    [No Abstract] [Full Text] [Related]

  • 26. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP, Ryzhikov AB, Bulychev LE, Sizov AA, Lebedev LR, Poryvaev VD, Karpenko LI, Il'ichev AA.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):630-5. PubMed ID: 12422616
    [Abstract] [Full Text] [Related]

  • 27. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
    Schöndorf I, Beran J, Cizkova D, Lesna V, Banzhoff A, Zent O.
    Vaccine; 2007 Feb 09; 25(8):1470-5. PubMed ID: 17196713
    [Abstract] [Full Text] [Related]

  • 28. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I, Jilg W, Bogdahn U, Steinbrecher A.
    Infection; 2007 Feb 09; 35(1):26-9. PubMed ID: 17297586
    [Abstract] [Full Text] [Related]

  • 29. [Early summer meningoencephalitis. Only vaccination offers protection].
    Paukstadt W.
    MMW Fortschr Med; 2004 Jun 24; 146(26):10. PubMed ID: 15529681
    [No Abstract] [Full Text] [Related]

  • 30. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I, Schönfeld C, Nicolay U, Zent O, Banzhoff A.
    Int J Med Microbiol; 2006 May 24; 296 Suppl 40():208-12. PubMed ID: 16531118
    [Abstract] [Full Text] [Related]

  • 31. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS, Rasshchepkina MN, Ladyzhenskaia IP, Gorbunov MA, Pavlova LI, Bektimirov TA.
    Vopr Virusol; 1996 May 24; 41(5):221-4. PubMed ID: 8967069
    [Abstract] [Full Text] [Related]

  • 32. High burden of tick-borne encephalitis in Slovenia--challenge for vaccination policy.
    Grgič-Vitek M, Klavs I.
    Vaccine; 2011 Jul 18; 29(32):5178-83. PubMed ID: 21620916
    [Abstract] [Full Text] [Related]

  • 33. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
    Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Koska M, Bobrovsky R, Konior R, Ehrlich HJ.
    Hum Vaccin; 2009 Aug 18; 5(8):551-6. PubMed ID: 19430202
    [Abstract] [Full Text] [Related]

  • 34. Seroepidemiologic study on tick-borne encephalitis among forestry workers and farmers from the Lublin region (eastern Poland).
    Cisak E, Sroka J, Zwoliński J, Umiński J.
    Ann Agric Environ Med; 1998 Aug 18; 5(2):177-81. PubMed ID: 9860820
    [Abstract] [Full Text] [Related]

  • 35. Study of the serological response after vaccination against tick-borne encephalitis in Sweden.
    Vene S, Haglund M, Lundkvist A, Lindquist L, Forsgren M.
    Vaccine; 2007 Jan 04; 25(2):366-72. PubMed ID: 16959384
    [Abstract] [Full Text] [Related]

  • 36. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Zent O, Plentz A, Schwarz TF, Frühwein N, Kuhr HB, Broeker M, Banzhoff A, Jilg W.
    Vaccine; 2004 Dec 02; 23(3):312-5. PubMed ID: 15530673
    [Abstract] [Full Text] [Related]

  • 37. Tick-borne encephalitis vaccines: past and present.
    Zent O, Bröker M.
    Expert Rev Vaccines; 2005 Oct 02; 4(5):747-55. PubMed ID: 16221075
    [Abstract] [Full Text] [Related]

  • 38. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
    Rendi-Wagner P, Paulke-Korinek M, Kundi M, Wiedermann U, Laaber B, Kollaritsch H.
    Vaccine; 2007 Jun 28; 25(27):5097-101. PubMed ID: 17555850
    [Abstract] [Full Text] [Related]

  • 39. [Active immunization against tick-borne encephalitis in the elderly].
    Biró J, Regius O.
    Z Gerontol; 1985 Jun 28; 18(6):337-9. PubMed ID: 3879415
    [Abstract] [Full Text] [Related]

  • 40. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R, Brzostek J, Poellabauer EM, Jiang Q, Harper L, Erber W.
    Vaccine; 2017 Jun 16; 35(28):3607-3613. PubMed ID: 28545923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.